The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Stem Cell Medicine
Jerusalem, Israel
B
11-50 Employees
2010
Key takeaway
Stem Cell Medicine is dedicated to creating cell therapy products that target chronic diseases, particularly neurological conditions like multiple sclerosis and pain. Their innovative treatments utilize adipose-derived mesenchymal cells and genetically modified muscle progenitor cells, highlighting their focus on advanced medical solutions.
Reference
Core business
Stem Cell Medicine Ltd.
Accellta
Haifa, Israel
B
11-50 Employees
2012
Key takeaway
Accellta specializes in innovative solutions for affordable and high-quality stem cell culturing, emphasizing their proprietary technology that enables the industrialization of stem cells without microcarriers. Their methods support the mass production of various stem cell types, including embryonic and induced pluripotent stem cells, which are crucial for applications in drug discovery and regenerative medicine.
Reference
Product
ES Cell lines - Accellta Ltd.
BioGenCell
Netanya, Israel
B
1-10 Employees
2008
Key takeaway
BioGenCell is dedicated to making personalized cell therapy a reality, particularly through its innovative TRACT technology that utilizes a patient's own blood for stem cell therapies. Their groundbreaking BGC101 cell therapy is currently being assessed in a Phase 2 Clinical Trial for treating Chronic Limb-Threatening Ischemia, aiming to transform the lives of patients with degenerative diseases.
Reference
Core business
Homepage - BioGenCell
Ushering in a New EraIn Cellular Medicine https://www.biogencell.net/wp-content/uploads/2023/04/cells-3-4-compress-v1.mp4 Personalized Treatments are produced from the patients’ own cells, mimicking the body’s’ natural processes. Innovative In three steps, we are able to provide every patient with a tailored treatment. Accessible We’re making personalized cell therapy a reality for every patient, with our patient and physician-friendly treatments Life-Changing […]
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
NewStem
Jerusalem, Israel
B
1-10 Employees
2016
Key takeaway
NewStem is a pioneering Bio-Platform company that develops precision medicine therapeutics and diagnostics, utilizing its proprietary haploid human embryonic stem cell (HhESC) technology. This innovative approach has the potential to advance cancer research and address unmet medical needs.
Reference
Core business
NewStem | Haploid HESC: Half the Genome - Infinite Potential
Our proprietary haploid human embryonic stem cell technology changes the paradigm to develop diagnostic (i.e., cancer), therapeutic & reproductive treatments.
Estar Technologies
Holon, Israel
B
- Employees
1992
Key takeaway
Estar Medical specializes in the innovation and development of medical devices for autologous regenerative biologics, notably through their patented platform for producing Autologous Platelet Rich Plasma (PRP) and related Cell Therapy technologies. Their products, including the Cellenis® Thrombin Rich Serum, are designed to enhance patient outcomes in various therapeutic applications.
Reference
Product
Cellenis TRS – Estar Medical
Hadasit
Jerusalem, Israel
B
11-50 Employees
1986
Key takeaway
Hadasit has developed clinical grade embryonic stem cells for multiple indications, highlighting its focus on advanced cell therapy solutions. Additionally, the establishment of Sakura Bio in 2022 further emphasizes the company's commitment to innovative healthcare advancements.
Reference
Product
Clinical grade embryonic stem cells for multiple indications - Hadasit - Health Innovation Engine
Kadimastem
Ness Ziona, Israel
B
11-50 Employees
2009
Key takeaway
Kadimastem is a clinical-stage biotechnology company focused on cell therapy, aiming to treat millions of patients with innovative regenerative therapies for unmet medical needs. Their unique platform includes the development of off-the-shelf cell-based products and involves patent-protected technology related to stem cells, particularly in the context of treatments for conditions like diabetes and muscular dystrophy.
Reference
Service
Technology | Kadimastem
Pluripotent stem cells תאי גזע עובריים טיפול בניוון שרירים ניוון שרירים ALS קדימהסטם
ADVA Biotechnologies
Haifa, Israel
B
11-50 Employees
2016
Key takeaway
Adva Biotechnology specializes in developing advanced therapies, particularly through its innovative automated autologous cell manufacturing platform. Their unique CAMP technology enhances the efficiency of cell therapy production, making it relevant to the field of stem cells.
Reference
Core business
Home // AdvaBio
VALUING LIFE Granting Advanced Therapies to Patients Automated Autologous Cell Manufacturing Platform Adva Biotechnology introduces the ADVA platform, a fully controlled, flexible, and automated cell processing platform. The system provides a solution to autologous cell therapy manufacturing processes using the unique CAMP (Continues Adaptive Multi-Parameter) technology.
Gamida Cell
Jerusalem, Israel
B
101-250 Employees
1998
Key takeaway
Gamida Cell is focused on developing innovative cell therapies, utilizing their proprietary NAM technology to create potentially curative treatments for cancer and other serious diseases.
Reference
Core business
Gamida Cell - Cell and Immune Therapy Technologies
Immunovative Therapies Ltd.
Jerusalem, Israel
B
11-50 Employees
2004
Key takeaway
The company, Mirror Biologics, Inc., specializes in the development of next-generation immunotherapy products using living immune cells. Their innovative Mirror Effect® technology platform enhances the immune response to target cancer and viral pathogens, potentially offering new solutions for immunotherapy.
Reference
Core business
Vaccines | Mirrorbio
Mirror Biologics, Inc. (“MBI”) is an international biopharmaceutical company specialized in development and manufacturing of next generation immunotherapy products where the active ingredients are living immune cells. www.mirrorbio.com
Technologies which have been searched by others and may be interesting for you:
The stem cell industry in Israel presents a dynamic landscape shaped by several key considerations. One of the foremost factors is the regulatory framework, which is known for its supportive yet stringent guidelines. The Israeli government encourages stem cell research and development, providing funding and resources while ensuring ethical compliance. However, navigating these regulations can be complex, so understanding local laws is essential. Additionally, Israel's robust academic infrastructure and research capabilities create abundant opportunities for innovation and collaboration. This environment fosters partnerships between universities and biotech firms, driving advancements in therapies and technologies. However, competition is fierce, with numerous startups and established companies vying for market share, making it crucial to identify unique value propositions. Environmental concerns also play a role, as sustainable practices in research and production are increasingly prioritized. The global market relevance of Israel's stem cell industry is significant, as the country is recognized as a leader in regenerative medicine and cell therapies. The international demand for such treatments offers a promising avenue for growth, but companies must also stay informed about global trends and advancements in the field. Overall, for those interested in the stem cell industry in Israel, a keen awareness of the regulatory environment, competitive dynamics, and innovative potential is vital for successful engagement.
Some interesting numbers and facts about your company results for Stem Cell
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 88 |
| Amount of suitable service providers | 29 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1986 |
| Youngest suiting company | 2016 |
Some interesting questions that has been asked about the results you have just received for Stem Cell
What are related technologies to Stem Cell?
Based on our calculations related technologies to Stem Cell are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Stem Cell?
The most represented industries which are working in Stem Cell are Medical, Biotechnology, Other, Healthcare, Pharmaceuticals
How does ensun find these Stem Cell Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
